Zero Cost-Sharing for PrEP: Increasing PrEP Access
Health HIV Webinar
While previous PrEP practice guidelines recommended that healthcare providers offer PrEP only to patients whom they considered "at high risk" of acquiring HIV, the most recent guidelines and the United States Preventive Services Task Force (USPSTF) recommendations are reshaping how providers think about PrEP. Expanded prescription of PrEP to previously overlooked patient populations is a key step towards reducing the spread of HIV. To achieve the maximum benefit of PrEP, compliance with current PrEP guidelines and enforcement of cost coverage for PrEP are important instruments for ending the HIV epidemic.
This webinar reviewed and provided guidance on the USPSTF FAQs including requirements for:
- Fully-covered PrEP-related ancillary tests and services with zero cost-sharing, as aligned with the CDC Clinical PrEP Guidelines.
- The lack of restrictions on frequency of PrEP initiation or the frequency of services, such as HIV and STI screening.
- Zero cost-sharing for the PrEP medication that is medically appropriate for patients, as determined by their healthcare provider.
- Easily accessible, transparent, and sufficiently expedient exceptions process if using reasonable medical management techniques.